Pelago Bioscience AB

Join Us at the Alzheimer’s Research UK Conference Pelago Bioscience is attending the Alzheimer’s Research UK Conference in Birmingham, February 25–26, the UK’s largest gathering of scientists dedicated to tackling neurodegenerative diseases. Representing Pelago Bioscience will be Regional Sales Manager, Mary Spanou, ready to discuss how CETSA® technology delivers biologically relevant insights to accelerate CNS drug discovery. Are you working on new treatments for neurodegenerative diseases? Let’s explore how we can support your drug discovery. Schedule a meeting here: https://hubs.ly/Q0375h7Q0 #DrugDiscovery #CETSA #AlzheimersResearch

Webinar: Applying CETSA® to Translational Studies – A Sitryx Story How do you bridge the gap between in vitro and in vivo data in drug discovery? Join us for an exclusive webinar to see how Sitryx Therapeutics leveraged Pelago Bioscience’s CETSA technology to strengthen confidence in their drug development pipeline. What you’ll learn: ✨How CETSA was applied to validate in vivo target engagement. ✨The impact of CETSA on translational drug development decisions. ✨A real-world case study of CETSA expediting drug development. Speaker: Jonathan Ellery, Director of Biology at Sitryx Therapeutics 📅: March 4th 🕙: 17:00 CET | 16:00 GMT | 11:00 EST | 08:00 PST Don’t miss this opportunity to gain insights into CETSA’s role in translational studies! 🔗 Register now: https://hubs.la/Q036L3QW0 #Webinar #DrugDiscovery #CETSA #targetengagement

Pelago Bioscience is heading to Boston for the Proteomics-Based Drug Discovery Summit, February 11–13. Julia Popp will represent Pelago Bioscience and be available to discuss how CETSA® technology provides biologically relevant insights and accelerates drug development. Attend Our Poster Presentation: "Enhancing degrader research with CETSA" If you're attending, don’t miss the chance to meet Julia and explore how Pelago Bioscience can support your research. Reach out to schedule a conversation: https://hubs.la/Q035zZ4x0 #ProteomicsSummit #DrugDiscovery #Proteomics #CETSA

Meet the Minds Behind CETSA® Technology. At Pelago Bioscience, we don’t just work with CETSA—we live and breathe it. Our founders, who developed this game-changing technology, share their journey in this inspiring story. From breakthrough academic research to building a company that partners with the world’s top pharmaceutical innovators, Pelago Bioscience is proud to be the home of CETSA. Watch the video to see how our passion for science and innovation turned a simple idea into a powerful tool in drug discovery. Watch the full story here: https://hubs.la/Q034Gtt20 Let us know how CETSA® has impacted your work or research in the comments! #CETSA #PelagoBioscience #DrugDiscovery #lifescience #Biopharma

Our latest webinar, "How CETSA® has been applied in Lead Generation delivering novel modulators of PLCγ2," is now available on-demand. Presented by Fiona Jeganathan, Head of Pharmacology and Screening at the Alzheimer's Research UK UCL Drug Discovery Institute, this session delves into: • The application of CETSA in discovering new modulators for Alzheimer's disease. • Innovative strategies for lead generation in drug discovery. • Expert insights into advancing pharmacological research. Don't miss this opportunity to gain valuable knowledge on CETSA and its impact on drug discovery. Watch the Webinar now: https://hubs.la/Q034tK7H0 #PelagoBioscience #CETSA #DrugDiscovery #AlzheimersResearch #Pharmacology

Pelago Bioscience is attending BII Demo Day on January 30th in Copenhagen, an event organized by the BioInnovation Institute. This gathering brings together biotech startups, investors, and industry leaders driving innovation in life sciences. Yasmin Andersson (Senior Project Advisor) and Magnus Lejelöv (Head of Sales) will be joining from Pelago Bioscience. They look forward to engaging with companies looking to accelerate drug discovery with CETSA® technology. Attending BII Demo Day? Let’s connect and explore new opportunities. Reach out to Yasmin Andersson or Magnus Lejelöv to schedule a conversation. See you in Copenhagen! #DrugDiscovery #BIIdemodays2025

Pelago Bioscience will attend EFMC-ISCB 2025 in Basel, January 29 to 31, and we’re excited to meet you there. Stop by Booth #8 to connect with our team, including Laurence Arnold (Head of R&D), Mitko Dimitrov (Regional Sales Manager), and Erwin Daniel Brenndörfer (Senior Project Advisor). Discover how our pioneering CETSA® technology delivers biologically relevant insights directly from natural cell environments, empowering drug discovery teams to minimize risks, prioritize compounds, and drive progress. Poster Presentation "A standardized selectivity profiling with a proteome coverage of more than 5,000 proteins" Presenter: Erwin Brenndörfer Friday, January 31, 13:00–14:00 Speaker Presentation "The Cellular Thermal Shift Assay Combined with Cell Painting and its Applications in MOA Determination" Presenter: Laurence Arnold Friday, January 31, 15:00, Session 6: Advances in High-Throughput Chemical Proteomics Whether you're looking to streamline your research or explore tailored solutions, we’re more than a CRO—we’re your dedicated partner in advancing your drug discovery journey. Visit us at Booth #8 or book a meeting here: https://hubs.la/Q033VfL70 🌐 Check our website for more information: https://hubs.la/Q033V7hj0 We look forward to seeing you in Basel. #ChemicalBiology #MedicinalChemistry #EFMC_ISCB2025 #DrugDiscovery

Pelago Bioscience is heading to SLAS 2025 in San Diego. We’re excited to join the life science and drug discovery community at SLAS from January 25th-29th. SLAS is always an excellent opportunity to connect, learn, and share the latest advancements in technology and innovation. Don’t miss our poster presentation: "Enhancing degrader research with CETSA" 📅 January 28th 🕙 2:00–3:00 pm Meet Helena Almqvist and Dan Campbell during the poster session to discuss how our CETSA® technology can empower your drug discovery projects. This is the perfect chance to explore how Pelago Bioscience can support you as an extended team in your drug discovery. Want to secure a meeting during SLAS? Click here to book time with us: https://hubs.la/Q033w6C80 🌐 Check our website for more information: https://hubs.la/Q033w8fV0 We look forward to connecting with you in San Diego! #SLAS25 #drugdiscovery

A big thank you to everyone who joined our webinar yesterday! Together with Fiona Jeganathan Head of Pharmacology and Screening at the Alzheimer's Research UK UCL Drug Discovery Institute, we showed how CETSA® technology is transforming lead generation by delivering novel modulators like PLCγ2. The session shed light on how CETSA helps confirm compound-target engagement, paving the way for breakthroughs in potential treatments for Alzheimer’s disease. Your participation and insightful questions were invaluable! For those who missed it, stay tuned as we’ll soon share key highlights and insights from the event. #drugdiscovery #CETSA #targetengagement #Webinar

Last chance to register for our December 4th webinar. Together with the Alzheimer's Research Drug Discovery Unit, University College of London we’re happy to invite you to a webinar on how CETSA® has been used to deliver novel modulators for potential new treatment of Alzheimer's disease. 📅 Date: December 4 🕓 Time: 17:00 CET | 16:00 GMT | 11:00 EST | 08:00 PST Register here: https://hubs.la/Q02-87kg0 #LeadGeneration #Webinar #Pharmacology #DrugDiscovery #LifeSciences